Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Paracetamol prices in Germany, the highest-cost reporting region, rose 3.0% in Q2 2026 to USD 3,400.00/MT from USD 3,300.00/MT in Q1, continuing this market's recovery from the sharp Q4 2025 correction. US prices, which had swung from USD 3,100.00/MT in Q1 2025 to USD 3,418.00/MT in Q2 before crashing to a two-year low of USD 3,050.00/MT in Q4, recovered further to USD 3,280.00/MT in Q2 2026. Globally, the average rose from USD 3,091.00/MT in Q1 to USD 3,181.40/MT in Q2, a 2.9% gain. For H2 2026, a global average of USD 2,900.00-3,300.00/MT is expected, with the market forecast leaning moderately stable as 2025's sharp swings gave way to a more balanced cost-price relationship.
Paracetamol, commonly known as acetaminophen in North America, is one of the most extensively used active pharmaceutical ingredients globally, produced through the acetylation of para-aminophenol, which itself derives from nitrobenzene. It is marketed across tablets, capsules, syrups, and effervescent powders, treating headaches, muscular pains, arthritis, and fever, and remains a staple over-the-counter medication in cold and flu formulations worldwide. This market experienced one of the more dramatic within-year price cycles of any pharmaceutical API tracked in this report, swinging from a supply-constrained first half of 2025 to a supply-abundant second half as high inventories, conservative distributor replenishment, and declining freight costs reduced procurement urgency. Para-aminophenol and nitrobenzene feedstock costs, OTC pharmaceutical demand seasonality, and distributor inventory cycles are what drive prices in this market.
The outlook for Paracetamol through H2 2026 is moderately stable, with the sharp Q4 2025 price correction having reset this market to levels broadly sustainable for both Chinese and Indian producers, creating a more balanced cost-price relationship heading into the back half of the year. Seasonal demand peaks for OTC cold, flu, and pain relief products in the Northern Hemisphere winter months should drive the typical annual procurement cycle, with Q3 procurement for winter season product launches expected to support prices later in the year.
The main upside risk is a significant disruption to Chinese nitrobenzene production, which would push para-aminophenol costs higher across every region tracked in this report. The main downside risk is a repeat of 2025's second-half inventory overhang, where high US inventories and abundant trans-Pacific shipment availability drove prices to a two-year low.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 2,900.00 - 3,300.00 | Moderately stable outlook after the Q4 2025 correction |
| Germany | 3,000.00 - 3,500.00 | Steady EU formulator demand sustains the highest cost |
| United States | 2,950.00 - 3,350.00 | Generic pharmaceutical and OTC formulator demand supports firmness |
| India | 2,750.00 - 3,100.00 | Growing indigenous production capacity drives continued gains |
| China | 2,700.00 - 3,000.00 | Large-scale nitrobenzene-integrated capacity keeps this the most affordable market |
German Paracetamol prices averaged USD 3,400.00/MT in Q2 2026, the highest of any region tracked here, up 3.0% from USD 3,300.00/MT in Q1, as steady EU formulator demand continued supporting this market's recovery.
Why did the price of Paracetamol change in Q2 2026 in Germany?
Steady demand from European formulators kept this market at the top of the range tracked in this report, continuing the recovery from the sharp Q4 2025 correction as the cost-price relationship reset to more sustainable levels.
US prices averaged USD 3,280.00/MT in Q2 2026, up 2.5% from USD 3,200.00/MT in Q1, as new formulation production cycles and generic pharmaceutical manufacturer demand continued driving gains.
Why did the price of Paracetamol change in Q2 2026 in the United States?
New formulation production cycles commenced, with procurement from generic pharmaceutical manufacturers and OTC product formulators sustaining buying momentum as the market recovered from its two-year Q4 2025 low.
Indian prices averaged USD 3,050.00/MT in Q2 2026, up 3.4% from USD 2,950.00/MT in Q1, as growing indigenous production capacity continued supporting this market.
Why did the price of Paracetamol change in Q2 2026 in India?
Growing domestic production capacity, following the successful commercialization of an indigenous manufacturing process, continued strengthening supply-chain security and supporting India's pharmaceutical self-reliance initiatives even as prices moved higher.
Chinese prices, the lowest of the four regions, averaged USD 2,930.00/MT in Q2 2026, up 2.8% from USD 2,850.00/MT in Q1, as large-scale nitrobenzene-integrated production capacity continued keeping this market the most affordable tracked in this report.
Why did the price of Paracetamol change in Q2 2026 in China?
Para-aminophenol costs remained broadly stable, with this market's large-scale integrated nitrobenzene-linked production capacity keeping Chinese offers the most competitive of any region tracked here even as global prices moved modestly higher.
German prices rose 4.8% in Q1 2026 to USD 3,300.00/MT from USD 3,150.00/MT in Q4 2025, recovering from the sharp Q4 correction.
Why did the price of Paracetamol change in Q1 2026 in Germany?
The sharp Q4 2025 price correction had reset Paracetamol to levels broadly sustainable for producers, creating a more balanced cost-price relationship heading into 2026 and supporting the Q1 recovery.
US prices recovered 4.9% in Q1 2026 to USD 3,200.00/MT from USD 3,050.00/MT in Q4 2025, the lowest quarterly level in two years, as new formulation production cycles commenced.
Why did the price of Paracetamol change in Q1 2026 in the United States?
Q1 2026 recovered toward the USD 3,200.00/MT level as new formulation production cycles commenced, following an H2 2025 correction in which high US inventories, conservative replenishment by distributors, abundant trans-Pacific shipment availability, and declining freight costs had reduced near-term procurement urgency.
Indian prices rose 5.4% in Q1 2026 to USD 2,950.00/MT from USD 2,800.00/MT in Q4 2025, recovering from the Q4 correction.
Why did the price of Paracetamol change in Q1 2026 in India?
The 2025 cycle demonstrated that paracetamol API markets can swing between tightness and oversupply within a single calendar year, with Q1 2026 marking a recovery from the fourth-quarter correction as procurement for H2 formulation cycles picked up.
Chinese prices rose 4.8% in Q1 2026 to USD 2,850.00/MT from USD 2,720.00/MT in Q4 2025, recovering as para-aminophenol costs stabilized.
Why did the price of Paracetamol change in Q1 2026 in China?
Para-aminophenol costs were expected to remain broadly stable barring a significant disruption to Chinese nitrobenzene production, with the Q1 2026 recovery reflecting the reset, more sustainable cost-price relationship following the sharp Q4 2025 correction.
Global Paracetamol prices swung dramatically through the period covered in this report, rising sharply through Q2 2025 on constrained supply before a pronounced H2 correction pulled prices to a two-year low in Q4, driven by high US inventories, conservative distributor replenishment, and abundant trans-Pacific shipment availability, before a recovery took hold through the first half of 2026 as new formulation production cycles commenced.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 3,181.40 | +2.9% | ↑ Rising |
| Q1 2026 | 3,091.00 | +4.9% | ↑ Rising |
| Q4 2025 | 2,945.40 | -8.1% | ↓ Falling |
| Q3 2025 | 3,204.00 | +1.1% | ↑ Rising |
| Q2 2025 | 3,170.68 | - | — Stable |
| Q3 2026 | In Progress | - | — In Progress |
Paracetamol told a genuinely volatile story across 2025, rising sharply through the first half of the year on constrained supply and OTC formulator demand before a pronounced H2 correction pulled every region down to multi-quarter lows by Q4, driven by high inventories, conservative distributor replenishment, and abundant trans-Pacific shipment availability.
German prices ended 2025 up modestly, from about USD 3,100.00/MT in Q1 to USD 3,150.00/MT by Q4, a gain of roughly 1.6%, masking a sharp mid-year rise to USD 3,400.00/MT in Q3 followed by a steep Q4 correction.
US prices ended 2025 down slightly, from about USD 3,100.00/MT in Q1 to USD 3,050.00/MT by Q4, down roughly 1.6%, after swinging as high as USD 3,418.00/MT in Q2 before the sharp H2 correction that followed.
Indian prices ended 2025 down slightly, from about USD 2,850.00/MT in Q1 to USD 2,800.00/MT by Q4, down roughly 1.8%, tracking the same mid-year rise and H2 correction pattern.
Chinese prices ended 2025 down slightly, from about USD 2,750.00/MT in Q1 to USD 2,720.00/MT by Q4, down roughly 1.1%, the smallest annual move of the four regions despite the sharp mid-year volatility.
Expert Market Research: Your Source for Real-Time Paracetamol Price Intelligence
Expert Market Research tracks Paracetamol prices continuously across every major producing and consuming region, combining para-aminophenol and nitrobenzene feedstock cost data, OTC pharmaceutical demand seasonality signals, and distributor inventory cycle trends into a single, regularly updated view of the market. Our team can help your procurement function benchmark current offers, plan purchases around the volatile trends covered in this report, and build a defensible view of where this essential analgesic API is headed next. Reach out to our team for a tailored briefing or a deeper look at any of the regional markets covered here.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is marketed across tablets, capsules, syrups, and effervescent powders, treating headaches, muscular pains, arthritis, and fever, and remains a staple over-the-counter medication in cold and flu formulations worldwide.
The Q2 2026 global average was USD 3,181.40/MT, ranging from USD 2,930.00/MT in China to USD 3,400.00/MT in Germany.
The global average rose from USD 2,945.40/MT in Q4 2025, a two-year low, to USD 3,091.00/MT in Q1 2026 and then to USD 3,181.40/MT in Q2, as new formulation production cycles commenced and demand recovered.
High US inventories, conservative replenishment by distributors, abundant trans-Pacific shipment availability, and declining freight costs reduced near-term procurement urgency, illustrating how paracetamol API markets can swing between tightness and oversupply within a single calendar year.
The global average is expected in the USD 2,900.00-3,300.00/MT range, with the market forecast leaning moderately stable as the cost-price relationship has reset to more sustainable levels.
China holds the lowest cost among the regions tracked here given large-scale nitrobenzene-integrated production capacity, while Germany carries the highest cost given steady European formulator demand.
This report is updated monthly. For real-time pricing intelligence, connect with the Expert Market Research team.
Para-aminophenol and nitrobenzene feedstock costs, OTC pharmaceutical demand seasonality, and distributor inventory cycles.
China maintains substantial nitrobenzene-integrated production capacity, while India has developed indigenous manufacturing technology reducing its historical dependence on imported raw materials.
Buyers can monitor para-aminophenol feedstock costs and distributor inventory cycles given their outsized influence on this market, time forward purchases around the quarterly breakdowns in this report, and consider a rolling 90 to 120 day procurement window given the scale of within-year volatility.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.